Abaxis Inc (NASDAQ:ABAX)

83.21
Delayed Data
As of Jun 22
 +0.32 / +0.39%
Today’s Change
43.66
Today|||52-Week Range
83.98
+68.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.6B

Company Description

ABAXIS, Inc. engages in the development, manufacture, and marketing of portable blood analysis systems. It operates through the following segments: Medical Market, Veterinary Market, and Other. The Medical Market segment serves a customer group consisting of physicians' office practices across multiple specialties, urgent care, outpatient and walk-in clinics, health screening operations, home care providers, nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies, hospital laboratories, military installations, pharmaceutical clinical trials, and cruise ship lines. The Veterinary Market segment focuses on animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies, and private research laboratories. The company was founded by Vladimir E. Ostoich in April 1989 and is headquartered in Union City, CA.

Contact Information

ABAXIS, Inc.
3240 Whipple Road
Union City California 94587
P:(510) 675-6500
Investor Relations:

Employees

Shareholders

Mutual fund holders60.38%
Individual stakeholders6.96%
Other institutional33.04%

Top Executives

Clinton H. SeversonChairman & Chief Executive Officer
Donald Peter WoodPresident & Chief Operating Officer
Ross TaylorCFO, Secretary & Vice President-Finance
Kenneth P. AronChief Technology Officer
Gregory BennettVice President-Engineering